These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1120 related articles for article (PubMed ID: 15302652)
1. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652 [TBL] [Abstract][Full Text] [Related]
2. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide. Lin JM; Chiu YT; Hung PT; Tsai YY Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200 [TBL] [Abstract][Full Text] [Related]
3. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion. Patel PJ; Zaheer I; Karia N Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Williamson TH; O'Donnell A Am J Ophthalmol; 2005 May; 139(5):860-6. PubMed ID: 15860292 [TBL] [Abstract][Full Text] [Related]
6. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Cekiç O; Chang S; Tseng JJ; Barile GR; Weissman H; Del Priore LV; Schiff WM; Weiss M; Klancnik JM Retina; 2005; 25(7):846-50. PubMed ID: 16205562 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion. Hayashi K; Hayashi H Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425 [TBL] [Abstract][Full Text] [Related]
8. Intravitreal triamcinolone for the management of macular edema due to nonischemic central retinal vein occlusion. Bashshur ZF; Ma'luf RN; Allam S; Jurdi FA; Haddad RS; Noureddin BN Arch Ophthalmol; 2004 Aug; 122(8):1137-40. PubMed ID: 15302653 [TBL] [Abstract][Full Text] [Related]
9. One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Gregori NZ; Rosenfeld PJ; Puliafito CA; Flynn HW; Lee JE; Mavrofrides EC; Smiddy WE; Murray TG; Berrocal AM; Scott IU; Gregori G Retina; 2006 Oct; 26(8):889-95. PubMed ID: 17031288 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion. Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289 [TBL] [Abstract][Full Text] [Related]
11. Early treatment of cystoid macular edema secondary to branch retinal vein occlusion with intravitreal triamcinolone acetonide. Yepremyan M; Wertz FD; Tivnan T; Eversman L; Marx JL Ophthalmic Surg Lasers Imaging; 2005; 36(1):30-6. PubMed ID: 15688969 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal triamcinolone acetonide for treatment of serous macular detachment in central retinal vein occlusion. Karacorlu M; Karacorlu SA; Ozdemir H; Senturk F Retina; 2007 Oct; 27(8):1026-30. PubMed ID: 18040239 [TBL] [Abstract][Full Text] [Related]
13. A comparison of three different intravitreal treatment modalities of macular edema due to branch retinal vein occlusion. Cekiç O; Cakır M; Yazıcı AT; Alagöz N; Bozkurt E; Faruk Yılmaz O Curr Eye Res; 2010 Oct; 35(10):925-9. PubMed ID: 20858114 [TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical efficacy of intravitreal ranibizumab with and without triamcinolone acetonide in macular edema secondary to central retinal vein occlusion. Fan C; Wang Y; Ji Q; Zhao B; Xie J Curr Eye Res; 2014 Sep; 39(9):938-43. PubMed ID: 24635755 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravitreal triamcinolone injection on macular edema and visual prognosis in central retinal vein occlusion. Ozdek SC; Aydin B; Gürelik G; Bahçeci U; Hasanreisoğlu B Int Ophthalmol; 2005; 26(1-2):27-34. PubMed ID: 16783483 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone for the treatment of ischemic macular edema associated with branch retinal vein occlusion. Chen SD; Sundaram V; Lochhead J; Patel CK Am J Ophthalmol; 2006 May; 141(5):876-883. PubMed ID: 16527226 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Haritoglou C; Kook D; Neubauer A; Wolf A; Priglinger S; Strauss R; Gandorfer A; Ulbig M; Kampik A Retina; 2006; 26(9):999-1005. PubMed ID: 17151486 [TBL] [Abstract][Full Text] [Related]
18. Intravitreal triamcinolone acetonide compared with bevacizumab for the treatment of patients with macular edema secondary to central retinal vein occlusion. Gokce G; Sobaci G; Durukan AH; Erdurman FC Postgrad Med; 2013 Sep; 125(5):51-8. PubMed ID: 24113663 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Krepler K; Ergun E; Sacu S; Richter-Müksch S; Wagner J; Stur M; Wedrich A Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561 [TBL] [Abstract][Full Text] [Related]
20. Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone. Gelston CD; Olson JL; Mandava N Acta Ophthalmol Scand; 2006 Jun; 84(3):314-8. PubMed ID: 16704690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]